Aytu BioPharma, Inc.AYTUNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, above historical average, structural decline.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-4.67M
↑ 68% above average
Average (9y)
$-14.55M
Historical baseline
Range
High:$1.41M
Low:$-29.04M
CAGR
-15.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | $-4.67M | -431.8% |
| 2024 | $1.41M | +143.0% |
| 2023 | $-3.27M | +88.3% |
| 2022 | $-27.96M | +3.7% |
| 2021 | $-29.04M | -137.9% |
| 2020 | $-12.21M | +16.4% |
| 2019 | $-14.61M | +4.2% |
| 2018 | $-15.25M | +15.9% |
| 2017 | $-18.13M | +16.9% |
| 2016 | $-21.81M | - |